StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
46
This month
1
This week
1
This year
2
Publishing Date
2024 - 04 - 16
1
2024 - 02 - 23
1
2023 - 11 - 01
1
2023 - 09 - 27
1
2023 - 09 - 25
1
2023 - 09 - 11
1
2023 - 09 - 07
1
2023 - 09 - 05
1
2023 - 09 - 04
2
2023 - 08 - 16
1
2023 - 08 - 14
1
2023 - 08 - 07
1
2023 - 06 - 16
1
2023 - 05 - 31
1
2023 - 05 - 12
1
2023 - 04 - 13
1
2023 - 04 - 12
1
2023 - 03 - 31
1
2023 - 03 - 28
1
2023 - 03 - 20
1
2023 - 02 - 23
1
2023 - 02 - 16
1
2023 - 01 - 17
1
2022 - 12 - 19
1
2022 - 12 - 15
1
2022 - 12 - 13
1
2022 - 11 - 03
1
2022 - 10 - 20
1
2022 - 10 - 06
1
2022 - 09 - 15
1
2022 - 09 - 05
1
2022 - 08 - 22
1
2022 - 08 - 03
1
2022 - 07 - 12
1
2022 - 06 - 29
1
2022 - 04 - 12
1
2022 - 03 - 17
1
2022 - 03 - 10
1
2022 - 03 - 07
1
2021 - 12 - 14
1
2021 - 10 - 28
1
2021 - 09 - 21
1
2021 - 07 - 29
1
2021 - 05 - 19
1
2021 - 03 - 22
1
Sector
Communications
1
Health technology
46
Manufacturing
3
N/a
4
Tags
Abbvie
1
Actinic keratosis
1
America
3
Application
2
Approval
3
Association
1
Biosimilar
1
Cancer
1
Children
1
China
1
Clinical-trials-phase-ii
1
Collaboration
1
Covid-19
1
Daxxify
2
Depression
1
Diabetes
1
Disease
1
Dravet syndrome
1
Drug
2
Events
2
Expansion
1
Eye
1
Fda
4
Fda-approvals
1
Fibromyalgia
1
Funding
1
Glargine
1
Global
9
Growing
2
Growth
15
Health
3
Hiv
2
Home
1
Impact
1
Infection
2
Injection
5
Insulin
1
International
1
License
1
Liver
1
Living
1
Market
29
Meeting
1
N/a
40
Offering
1
Order
1
Osteoporosis
1
Parkinson
1
Pharma
2
Reach
3
Regulatory
1
Report
4
Research
11
Risk
1
Ryzumvl
1
Sclerosis
2
Set
1
System
1
Tentative
1
Treatment
45
Entities
3m company
21
Abbott laboratories
60
Abbvie inc.
121
Accuray incorporated
21
Adamis pharmaceuticals corporation
19
Adial pharmaceuticals, inc
22
Alnylam pharmaceuticals, inc.
38
Amgen inc.
47
Arcutis biotherapeutics, inc.
25
Arrowhead pharmaceuticals, inc.
21
Astellas pharma inc
51
Astrazeneca plc
52
Bausch health companies inc.
36
Biogen inc.
42
Biohaven pharmaceutical holding company ltd.
19
Bioxcel therapeutics, inc.
20
Boston scientific corporation
21
Brainsway ltd.
41
Bridgebio pharma, inc.
20
Bristol-myers squibb company
94
Cns pharmaceuticals, inc.
26
Coherus biosciences, inc.
28
Compass pathways plc
20
Ecolab inc.
47
Eli lilly and company
180
Fortress biotech, inc.
27
Gilead sciences, inc.
50
Glaxosmithkline plc
103
Hoth therapeutics, inc.
24
Incyte corporation
77
Intellia therapeutics, inc.
32
Jazz pharmaceuticals plc
20
Johnson & johnson
208
Karyopharm therapeutics inc.
33
Koninklijke philips n.v.
21
Medicinova, inc.
24
Medtronic plc
46
Merck & company, inc.
65
Moleculin biotech, inc.
28
Novartis ag
144
Novo nordisk a/s
37
Nrx pharmaceuticals inc
20
Orange
87
Perrigo company
21
Pfizer, inc.
74
Reata pharmaceuticals, inc.
28
Regeneron pharmaceuticals, inc.
57
Regenxbio inc.
25
Sanofi
294
Sorrento therapeutics, inc.
37
Takeda pharmaceutical company limited
54
Teleflex incorporated
21
Teva pharmaceutical industries ltd
79
Tg therapeutics, inc.
24
Tonix pharmaceuticals holding corp.
32
Ultragenyx pharmaceutical inc.
25
Verrica pharmaceuticals inc.
23
Vertex pharmaceuticals incorporated
27
Viatris inc.
46
Xylem inc.
35
Symbols
ABBV
10
ABT
7
ALPMF
1
ALPMY
1
AMGN
6
ATAI
1
ATNX
1
AVDL
1
AZN
3
AZNCF
3
BAX
2
BHC
7
BMY
3
CMXHF
1
CSLLY
1
ENDP
3
ENDPQ
3
FNCTF
1
GILD
2
GLAXF
13
GSK
16
JAZZ
2
JNJ
6
KIDS
1
LGND
1
LLY
6
MREO
1
NNOX
1
NVS
20
NVSEF
19
OCUP
1
PBH
1
PHG
1
PRGO
1
RARE
1
RVNC
4
SNY
12
SNYNF
11
TAK
2
TARO
1
TEVA
2
TEVJF
19
TMO
1
TNXP
2
UCBJF
1
UCBJY
1
VRNA
1
VTRS
46
XENE
1
Exchanges
Nasdaq
46
Nyse
30
Crawled Date
2024 - 04 - 16
1
2024 - 02 - 23
1
2023 - 11 - 01
1
2023 - 09 - 27
1
2023 - 09 - 25
1
2023 - 09 - 11
1
2023 - 09 - 08
1
2023 - 09 - 05
1
2023 - 09 - 04
2
2023 - 08 - 16
1
2023 - 08 - 14
1
2023 - 08 - 07
1
2023 - 06 - 16
1
2023 - 06 - 01
1
2023 - 05 - 12
1
2023 - 04 - 13
1
2023 - 04 - 12
1
2023 - 03 - 31
1
2023 - 03 - 28
1
2023 - 03 - 21
1
2023 - 02 - 23
1
2023 - 02 - 16
1
2023 - 01 - 17
1
2022 - 12 - 20
1
2022 - 12 - 15
1
2022 - 12 - 13
1
2022 - 11 - 03
1
2022 - 10 - 20
1
2022 - 10 - 06
1
2022 - 09 - 15
1
2022 - 09 - 05
1
2022 - 08 - 22
1
2022 - 08 - 03
1
2022 - 07 - 12
1
2022 - 06 - 29
1
2022 - 04 - 12
1
2022 - 03 - 17
1
2022 - 03 - 10
1
2022 - 03 - 07
1
2021 - 12 - 14
1
2021 - 10 - 28
1
2021 - 09 - 21
1
2021 - 07 - 29
1
2021 - 05 - 19
1
2021 - 03 - 22
1
Crawled Time
00:00
4
01:00
2
02:00
3
03:00
2
04:00
2
06:00
2
08:00
3
09:00
4
12:00
3
12:30
1
13:00
2
14:00
4
15:00
2
15:30
1
16:00
1
17:00
1
18:00
1
19:00
4
21:00
1
22:00
2
23:00
1
Source
www.biospace.com
6
www.globenewswire.com
1
www.prnewswire.com
39
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
treatment
entities :
Viatris inc.
save search
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
-1.77%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-1.19%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
$19.98
-0.84%
0.0%
500K
|
Health Technology
|
-2.52%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
-2.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$16.1
-1.83%
-1.86%
490K
|
Health Technology
|
1.9%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Binge-eating Disorder Treatment Market Research Report 2024
Published:
2024-02-23
(Crawled : 02:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
-16.77%
|
O:
0.0%
H:
1.93%
C:
1.27%
TNXP
|
$0.1549
-2.82%
-2.91%
1.4M
|
Health Technology
|
-49.43%
|
O:
0.0%
H:
4.3%
C:
1.77%
report
treatment
research
market
Clonidine Micropellet Epidural Injections Fuel Growth in Global Sciatica Treatment Market
Published:
2023-11-01
(Crawled : 23:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
24.66%
|
O:
0.67%
H:
0.22%
C:
-0.56%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-1.25%
|
O:
-1.09%
H:
1.03%
C:
0.91%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-2.7%
|
O:
-0.89%
H:
0.0%
C:
0.0%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-0.28%
|
O:
3.0%
H:
0.0%
C:
0.0%
treatment
global
growth
market
Ocuphire Pharma and Viatris Announce FDA Approval of RYZUMVI™ (Phentolamine Ophthalmic Solution) 0.75% Eye Drops for the Treatment of Pharmacologically-Induced Mydriasis Produced by Adrenergic Agonists (e.g., Phenylephrine) or Parasympatholytic (e.g., Tropicamide) Agents
Published:
2023-09-27
(Crawled : 12:00)
- globenewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
14.4%
|
O:
0.0%
H:
1.03%
C:
-1.34%
OCUP
|
$1.675
-3.74%
-3.88%
240K
|
Health Technology
|
-58.46%
|
O:
0.75%
H:
3.46%
C:
-6.67%
fda
pharma
approval
treatment
eye
ryzumvl
The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, and more among key companies- Technavio
Published:
2023-09-25
(Crawled : 03:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
8.89%
|
O:
-0.81%
H:
1.63%
C:
-1.03%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
12.99%
|
O:
3.72%
H:
0.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
15.35%
|
O:
-0.21%
H:
1.14%
C:
1.04%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-7.97%
|
O:
-0.31%
H:
0.98%
C:
0.97%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
5.8%
|
O:
-0.13%
H:
0.91%
C:
0.88%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
7.94%
|
O:
-0.24%
H:
0.0%
C:
0.0%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
7.61%
|
O:
-1.17%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
-1.03%
|
O:
-0.06%
H:
0.1%
C:
-0.25%
abbvie
treatment
thyroid
market
Female Sexual Dysfunction Treatment Market to grow by USD 7.76 billion from 2022-2027; North America to account for 61% of market growth - Technavio
Published:
2023-09-11
(Crawled : 08:00)
- prnewswire.com
ENDPQ
|
$0.0006
-50.0%
620K
|
n/a
|
-60.0%
|
O:
0.0%
H:
10.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
9.99%
|
O:
0.4%
H:
0.69%
C:
-1.38%
america
treatment
growth
market
Advancements in Atherosclerosis Treatments Fuel Expansion of the Global Market to 2032
Published:
2023-09-07
(Crawled : 00:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
11.2%
|
O:
0.0%
H:
2.1%
C:
1.1%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-5.84%
|
O:
-0.29%
H:
0.38%
C:
-0.22%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-9.43%
|
O:
-0.34%
H:
0.0%
C:
0.0%
BHC
|
$8.6
-0.69%
0.0%
2.1M
|
Health Technology
|
3.8%
|
O:
0.0%
H:
3.09%
C:
2.61%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
-14.5%
|
O:
0.46%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
4.15%
|
O:
0.53%
H:
1.79%
C:
1.44%
expansion
global
market
Viatris Announces U.S. FDA Tentative Approval of a Paediatric Formulation of Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC), a Once-daily Treatment for Children Living with HIV
Published:
2023-09-05
(Crawled : 09:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
3.06%
|
O:
0.0%
H:
0.88%
C:
-1.58%
fda
tentative
children
approval
treatment
hiv
living
Addressing the Fragile: 2023 Global Osteogenesis Imperfecta Treatment Market's Growth Driven by Research and Collaboration
Published:
2023-09-04
(Crawled : 16:00)
- prnewswire.com
MREO
|
$2.66
3.1%
3.01%
810K
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
KIDS
|
$29.485
-1.39%
-1.41%
81K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
RARE
F
|
$43.38
-1.65%
-1.68%
770K
|
Health Technology
|
Email alert
Add to watchlist
treatment
research
global
collaboration
growth
Binge-eating Disorder Treatment Market size is set to grow by USD 578.04 million from 2022 to 2027 | The increasing prevalence of binge-eating disorder drives the market - Technavio
Published:
2023-09-04
(Crawled : 15:30)
- prnewswire.com
TNXP
|
$0.1549
-2.82%
-2.91%
1.4M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
treatment
set
market
Global Biosimilars Market Analysis 2023 - 2030: Delivering Accessible Treatment Options and the Future of Healthcare
Published:
2023-08-16
(Crawled : 01:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
-0.36%
|
O:
-0.99%
H:
1.45%
C:
1.36%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
8.92%
|
O:
0.56%
H:
0.0%
C:
0.0%
AMGN
|
$262.77
-0.49%
-0.49%
2M
|
Health Technology
|
1.48%
|
O:
2.02%
H:
0.72%
C:
-0.49%
treatment
global
market
U.S. FDA Approves First Therapeutic Indication for Revance’s DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia
Published:
2023-08-14
(Crawled : 13:00)
- biospace.com/
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
-2.03%
|
O:
-0.35%
H:
0.0%
C:
-1.06%
RVNC
|
$3.8
1.06%
1.05%
1.6M
|
Health Technology
|
-80.12%
|
O:
6.13%
H:
1.54%
C:
-3.04%
daxxify
fda
treatment
injection
Viatris and Mapi Pharma Announce FDA Acceptance of New Drug Application Filing for GA Depot for the Treatment of Relapsing Forms of Multiple Sclerosis
Published:
2023-08-07
(Crawled : 12:00)
- biospace.com/
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
5.0%
|
O:
2.46%
H:
5.81%
C:
1.38%
fda
pharma
drug
sclerosis
treatment
application
Fibromyalgia Treatment Market to Reach $4.6 Billion, Globally, by 2032 at 4.0% CAGR: Allied Market Research
Published:
2023-06-16
(Crawled : 14:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
11.25%
|
O:
0.75%
H:
0.14%
C:
0.14%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
11.87%
|
O:
0.6%
H:
3.2%
C:
2.9%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-8.2%
|
O:
1.03%
H:
0.29%
C:
-0.59%
LLY
|
$745.95
-0.64%
-0.1%
1.7M
|
Health Technology
|
65.39%
|
O:
0.41%
H:
0.26%
C:
-1.77%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
21.54%
|
O:
0.6%
H:
1.62%
C:
1.42%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
1.31%
|
O:
0.4%
H:
1.07%
C:
0.72%
fibromyalgia
reach
treatment
research
market
Global HIV Treatment Market Report 2023: Advances in Gene Therapy Present Significant Opportunities for Sector Growth
Published:
2023-05-31
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
21.03%
|
O:
-0.24%
H:
2.1%
C:
2.1%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
21.53%
|
O:
0.0%
H:
0.66%
C:
0.33%
TEVA
|
$12.78
-3.03%
-0.24%
9M
|
Health Technology
|
83.06%
|
O:
0.42%
H:
0.83%
C:
-0.41%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-6.52%
|
O:
-0.34%
H:
0.32%
C:
0.0%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
17.86%
|
O:
-0.24%
H:
1.43%
C:
0.84%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-25.05%
|
O:
0.03%
H:
0.41%
C:
0.34%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
19.72%
|
O:
-1.96%
H:
0.0%
C:
-1.35%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
4.31%
|
O:
-0.09%
H:
0.97%
C:
0.89%
GILD
|
News
|
$66.16
-1.15%
-1.16%
6.4M
|
Health Technology
|
-13.05%
|
O:
0.78%
H:
0.0%
C:
-1.72%
report
treatment
global
hiv
therapy
growth
market
Amyotrophic Lateral Sclerosis Treatment Market to Reach $1.0 Billion, Globally, by 2032 at 4.6% CAGR: Allied Market Research
Published:
2023-05-12
(Crawled : 14:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
18.8%
|
O:
0.21%
H:
0.21%
C:
-1.07%
reach
sclerosis
treatment
research
market
Lennox-Gastaut syndrome treatment market to grow at a CAGR of 4.42%: Cedars-Sinai Health System and Cision Ltd among key vendors - Technavio
Published:
2023-04-13
(Crawled : 01:00)
- prnewswire.com
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
-12.06%
|
O:
2.76%
H:
0.0%
C:
-0.26%
CSLLY
|
$87.96
3.3%
45K
|
n/a
|
-13.34%
|
O:
0.44%
H:
0.83%
C:
0.51%
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
8.89%
|
O:
0.54%
H:
0.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
13.24%
|
O:
0.31%
H:
1.42%
C:
0.71%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
5.01%
|
O:
0.85%
H:
0.76%
C:
0.76%
AVDL
|
$17.4
-3.28%
-3.39%
1.1M
|
Health Technology
|
78.44%
|
O:
0.21%
H:
6.44%
C:
4.41%
health
treatment
system
market
Ewing's Sarcoma Treatment Market size to grow by USD 302.5 million from 2021 to 2026, Driven by the growing awareness about and funding for Ewing's sarcoma - Technavio
Published:
2023-04-12
(Crawled : 08:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
8.02%
|
O:
1.63%
H:
0.0%
C:
-2.39%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
17.97%
|
O:
1.1%
H:
0.0%
C:
0.0%
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
12.21%
|
O:
0.71%
H:
0.3%
C:
-1.6%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-2.84%
|
O:
0.75%
H:
0.5%
C:
-0.05%
GSK
|
$39.27
-0.83%
0.01%
2.2M
|
Health Technology
|
6.02%
|
O:
1.15%
H:
0.39%
C:
-0.19%
BAX
|
$39.65
0.33%
0.0%
2.3M
|
Health Technology
|
-7.44%
|
O:
0.47%
H:
0.8%
C:
-0.97%
BHC
|
$8.6
-0.69%
0.0%
2.1M
|
Health Technology
|
14.7%
|
O:
1.31%
H:
0.26%
C:
-4.4%
treatment
growing
funding
market
Sleep Disorders Treatment Global Market Report 2023: Growing Demand for Home Sleep Tests Presents Opportunities
Published:
2023-03-31
(Crawled : 19:00)
- prnewswire.com
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
Email alert
Add to watchlist
JAZZ
|
$109.3
2.05%
2.01%
560K
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
report
treatment
global
growing
home
market
Motion Sickness Treatment Market to Reach $525 Million, Globally, by 2031 at 2.9% CAGR: Allied Market Research
Published:
2023-03-28
(Crawled : 15:00)
- prnewswire.com
VTRS
|
$11.11
0.09%
0.09%
3.5M
|
Health Technology
|
17.42%
|
O:
-0.42%
H:
1.06%
C:
1.06%
TEVA
|
$12.78
-3.03%
-0.24%
9M
|
Health Technology
|
50.97%
|
O:
-0.46%
H:
1.84%
C:
0.81%
PBH
|
$68.35
0.47%
0.0%
220K
|
Health Technology
|
8.94%
|
O:
-0.5%
H:
1.17%
C:
0.84%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
3.1%
|
O:
-0.38%
H:
1.25%
C:
1.12%
BAX
|
$39.65
0.33%
0.0%
2.3M
|
Health Technology
|
-0.92%
|
O:
-0.45%
H:
0.83%
C:
-0.1%
ABT
|
News
|
$105.27
-0.6%
-0.15%
7.3M
|
Health Technology
|
8.06%
|
O:
-0.37%
H:
0.14%
C:
-1.01%
treatment
research
market
← Previous
1
2
3
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.